What is the recommendation for managing significantly elevated triglycerides?

Management of Triglycerides at 1474 mg/dL

Immediate Action Required

You must initiate fenofibrate 54-160 mg daily immediately to prevent acute pancreatitis, while simultaneously implementing extreme dietary fat restriction (<5% of total calories), complete elimination of all added sugars and alcohol, and urgent evaluation for uncontrolled diabetes or hypothyroidism. 1, 2

At 1474 mg/dL, your patient is at very high risk for acute pancreatitis and requires emergency intervention. 1, 2

---

Why Fenofibrate Must Be Started Immediately

• Fibrates are first-line therapy for severe hypertriglyceridemia (≥500 mg/dL) to prevent acute pancreatitis, not statins. 3, 4
• Fenofibrate reduces triglycerides by 30-50%, which should bring levels from 1474 mg/dL to approximately 737-1032 mg/dL. 1, 4
• Do not start with statin monotherapy at this triglyceride level—statins provide only 10-30% triglyceride reduction and are insufficient for preventing pancreatitis when triglycerides exceed 500 mg/dL. 1
• The FDA label explicitly states fenofibrate is indicated for severe hypertriglyceridemia, with initial dosing of 54-160 mg daily. 4

---

Critical Dietary Interventions (Start Today)

• Restrict total dietary fat to <5% of total calories until triglycerides fall below 1,000 mg/dL, as pharmacotherapy has limited effectiveness above this threshold. 5, 1, 2
• Once below 1,000 mg/dL, increase fat to 10-15% of total calories. 5, 2
• Eliminate all added sugars completely—sugar intake directly increases hepatic triglyceride production. 5, 1, 2
• Abstain completely from all alcohol—alcohol synergistically increases triglycerides and can precipitate hypertriglyceridemic pancreatitis at these levels. 5, 1, 2
• Increase soluble fiber to >10 g/day from sources like oats, beans, and vegetables. 5

---

Urgent Assessment for Secondary Causes (Order These Labs Now)

• Check HbA1c and fasting glucose immediately—uncontrolled diabetes is often the primary driver of severe hypertriglyceridemia. 5, 1, 2
• Optimizing glucose control can dramatically reduce triglycerides independent of lipid medications and may obviate the need for additional therapy. 5, 1
• Check TSH—hypothyroidism is a common secondary cause. 5, 1
• Review medications: thiazide diuretics, beta-blockers, estrogen therapy, corticosteroids, antiretrovirals, and antipsychotics should be discontinued or substituted if possible. 5, 4
• Assess renal and liver function before initiating fenofibrate. 4

---

Monitoring Strategy

• Reassess fasting lipid panel in 4-8 weeks after initiating fenofibrate and implementing dietary changes. 5, 1
• Monitor for muscle symptoms and obtain baseline and follow-up creatine kinase (CPK) levels when using fenofibrate. 5, 1
• Lipid levels should be monitored periodically, with repeat determinations at 4-8 week intervals. 4

---

Add-On Therapy if Triglycerides Remain Elevated

• If triglycerides remain >500 mg/dL after 3 months of fenofibrate plus optimized lifestyle, consider adding prescription omega-3 fatty acids (icosapent ethyl 2-4g daily) as adjunctive therapy. 5, 1, 2
• Once triglycerides fall below 500 mg/dL, reassess LDL-C and consider adding statin therapy if LDL-C is elevated or cardiovascular risk is high. 5, 1, 2
• Icosapent ethyl is specifically indicated for patients with triglycerides ≥150 mg/dL on maximally tolerated statin with established cardiovascular disease OR diabetes with ≥2 additional risk factors. 5, 1

---

Critical Pitfalls to Avoid

• Do not delay fenofibrate initiation while attempting lifestyle modifications alone—pharmacologic therapy is mandatory at this triglyceride level to prevent pancreatitis. 1
• Do not ignore secondary causes, particularly uncontrolled diabetes and hypothyroidism—treating these may be more effective than additional lipid medications. 5, 1, 2
• Do not use gemfibrozil instead of fenofibrate—gemfibrozil has significantly higher myopathy risk when combined with statins and should be avoided. 5, 6
• If combining fenofibrate with statins in the future, use lower statin doses (atorvastatin 10-20 mg maximum) to minimize myopathy risk. 5

---

Expected Outcomes

• Goal: Rapid reduction to <500 mg/dL to eliminate pancreatitis risk, followed by further reduction to <200 mg/dL (ideally <150 mg/dL) to reduce cardiovascular risk. 5, 1
• With fenofibrate 160 mg daily plus extreme dietary fat restriction, expect triglycerides to decrease by 50-70% within 4-8 weeks. 1, 4
• If uncontrolled diabetes is present and optimized, this alone can produce dramatic triglyceride reductions independent of fenofibrate. 5, 1, 2